Thus, the incidence of mutations in STAG2, SRSF2, RUNX1, EZH2, ASXL1, ZRSR2 and IDH2 was higher in the isolated +8 MDS group than in the control cohort (p < 0.05). The gene discussed is RUNX1; the disease is myelodysplastic syndrome.